Mu‐Chen Zhang

机构：Ruijin Hospital, Shanghai Institute of Hematology · ORCID：0000-0002-4772-5717

发表论文 47 篇 · 总被引 582 次 · h-index 9

代表论文

• Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial (2023 · Cancer Cell · 被引 122)
• Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma (2023 · Signal Transduction and Targeted Therapy · 被引 104)
• Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma (2023 · Signal Transduction and Targeted Therapy · 被引 39)
• Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma (2024 · Blood Advances · 被引 21)
• A qualitative study exploring the experiences and needs of fear of disease progression in patients after open-heart surgery (2024 · Journal of Psychosomatic Research · 被引 9)
• CSNK1E sustains stemlike drug persistence in diffuse large B-cell lymphoma (2026 · Blood · 被引 2)